Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
CSO
Mike has a Ph.D in Biochemistry and Molecular Biology from Columbia University, as well as a Bachelor of Science magna cum laude in Chemistry and Biophysics from Hampden-Sydney College. Prior to joining the HPNE team, Mike Quesenberry began as an instrumentation scientist supporting dynamic light scattering and circular dichroism. He then transitioned into process development work at preclinical companies like Avaxia, Xencor, and Werewolf Therapeutics, and larger Phase I/II biotechs such as BMS, Pfizer, Lonza, and Pall Life Sciences. At Pall, Mike started as subject matter expert across the portfolio and finished as certified trainer for all product lines. Among his other accomplishments, he has 2 patents to his name, and he has published more than 16 peer-reviewed Glycobiology-focused articles in the course of his research career.